Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?

Purpose of reviewWe reviewed clinical trials on active and passive anti-β-amyloid (Aβ) immunotherapy for the treatment of Alzheimer's disease with a particular focus on monoclonal antibodies against Aβ.Recent findingsStudies on anti-Alzheimer's disease immunotherapy published in the period from Janu